166 F. Supp. 3d 822
S.D. Tex.2016Background
- Lead Plaintiff (a putative class) sued Key Energy Services and several officers under §10(b)/Rule 10b-5, §20(a), and alleged FCPA-related misstatements/omissions during Sep 4, 2012–Jul 17, 2014, tied to Key’s international operations (Mexico, Russia).
- Plaintiffs allege Defendants misrepresented Key’s FCPA compliance program (Code of Conduct and FCPA Manual), and touted growth in Mexico/Russia without disclosing that revenue was driven by FCPA violations and inadequate internal controls.
- The complaint relied heavily on six confidential witnesses (CWs), internal-policy documents, company public statements and SEC filings (including SOX certifications) to plead falsity, scienter, and loss causation; it alleges eventual SEC/DOJ inquiries and goodwill impairments revealed the truth.
- Defendants moved to dismiss under Rules 9(b) and 12(b)(6) and the PSLRA’s heightened pleading standards, arguing the statements were puffery/forward-looking, CW allegations were speculative or non‑particular, scienter was not pleaded, and loss causation was not established because investigations alone are not corrective disclosures.
- The court reviewed governing pleading doctrines (Twombly/Iqbal, PSLRA, Rule 9(b), Tellabs) and FCPA/accounting background, and found the complaint failed to meet the PSLRA/Rule 9(b) particularity and scienter requirements.
- Court granted defendants’ motions to dismiss but granted leave to amend within 20 days, explaining the principal pleading deficiencies (lack of particularized falsity, insufficient specific facts tying CWs to defendants or to actual FCPA violations, failure to plead strong inference of scienter, and inadequate loss‑causation allegations).
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Falsity of Code/Manual statements | Code/Manual falsely represented effective FCPA compliance and internal controls | Those statements are aspirational puffery/forward‑looking and not literally false; no particularized facts show falsity when made | Dismissed — plaintiff failed to plead particularized facts showing the Code/Manual were false when made |
| Falsity of statements re: Mexico/Russia growth | Growth was actually driven by undisclosed FCPA violations; statements omitted that truth | Plaintiffs plead no specific FCPA violations or that revenue stemmed from bribery; statements were forward‑looking/puffery or disclosed risk | Dismissed — insufficient particularized allegations that FCPA violations occurred and caused the growth alleged |
| Reliance / fraud‑on‑the‑market presumption | Market relied on public statements; class trading during period supports presumption | Plaintiffs must also show market efficiency and corrective disclosures linking misstatements to price drops; defendants say disclosures merely announced investigations | Not adjudicated on merits; court noted plaintiffs must plead corrective disclosures and market impact with particularity; present pleading inadequate |
| Scienter (state of mind) | Knowledge or severe recklessness inferred from (a) alleged widespread FCPA violations across countries, (b) Defendants’ positions and access, (c) eventual investigations and impairments | Group pleading, title‑based inferences insufficient; CWs do not allege communications to or knowledge by individual defendants; no motive or suspicious stock sales | Dismissed — plaintiff failed to plead a strong, cogent and compelling inference of scienter for each individual defendant |
| Reliance on Confidential Witnesses | CWs provide eyewitness/internal support for falsity and scienter | CW allegations are vague, lack dates/job specifics, and do not show CWs told defendants or that CWs observed specific FCPA violations affecting reported results | Dismissed (as pleaded) — court discounted CW allegations for lack of particularity and corroboration |
| SOX certifications alleged false | CEO/CFO certifications were false because they concealed material weaknesses in controls and FCPA exposure | SOX certifications concern internal control over financial reporting, not FCPA policies; plaintiff fails to identify specific accounting red flags or any restatement tied to defendants’ conduct | Dismissed — plaintiffs failed to plead particularized facts showing certifiers knew of material weaknesses or were severely reckless |
| Loss causation | Stock price drops after disclosures (May and July 2014) show corrective disclosures and proximate cause | Government investigations alone do not necessarily constitute corrective disclosures; price moves may be caused by other factors and linkage to prior misstatements is not pleaded | Dismissed — plaintiffs failed to plead plausible loss causation tying the alleged prior misstatements to corrective disclosures and price declines |
| Control‑person liability (§20(a)) | Officers are liable as controllers for §10(b) primary violations | §20(a) derivative; fails with dismissal of primary claims | Dismissed — derivative claims fail because primary §10(b) claims were dismissed |
Key Cases Cited
- Bell Atlantic Corp. v. Twombly, 550 U.S. 544 (2007) (plaintiff must plead facts sufficient to state a plausible claim)
- Ashcroft v. Iqbal, 556 U.S. 662 (2009) (legal conclusions unsupported by factual allegations are insufficient)
- Tellabs, Inc. v. Makor Issues & Rights, Ltd., 551 U.S. 308 (2007) (court must weigh competing inferences to determine whether pleaded facts give rise to a strong inference of scienter)
- Basic Inc. v. Levinson, 485 U.S. 224 (1988) (fraud‑on‑the‑market presumption of reliance in an efficient market)
- Dura Pharmaceuticals, Inc. v. Broudo, 544 U.S. 336 (2005) (plaintiff must plead economic loss and proximate causation; inflated purchase price alone insufficient)
- Shaw Group, Inc. v. Triplefine Int’l Corp., 537 F.3d 527 (5th Cir. 2008) (PSLRA/§78u‑4/particularity and scienter standards; discounted reliance on confidential witnesses)
- Southland Securities Corp. v. INSpire Ins. Solutions, Inc., 365 F.3d 353 (5th Cir. 2004) (PSLRA pleading requirements; group‑pleading prohibition)
- Nathenson v. Zonagen, Inc., 267 F.3d 400 (5th Cir. 2001) (elements of a §10(b)/Rule 10b‑5 claim and scienter standard)